Molecule of the month. Elesclomol and obatoclax mesylate.
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology* / Q000627:therapeutic use; D007211:Indoles; D008545:Melanoma / Q000188:drug therapy; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000188:drug therapy; D011758:Pyrroles / Q000494:pharmacology* / Q000627:therapeutic use
D000970:Antineoplastic Agents; D006834:Hydrazines; D007211:Indoles; D011758:Pyrroles; C512195:elesclomol; C520962:obatoclax